Statistics on Biotechnology Use  
Results by fields of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: 

;Total 2020;Companies;P.A.;Higher Education;PNPI;
Companies that perform R+D in Biotechnology;1.430;1.233;118;67;12;
%Companies according to biotechnology used: Genetic code;39,1;31,7;89;86,6;41,7;
%Companies according to biotechnology used: Functional Companies;45,2;38,5;88,1;91;58,3;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;30,1;22,8;73,7;80,6;75;
%Companies according to biotechnology used: Bioprocesses;55,7;53,4;57,6;94;58,3;
%Companies according to biotechnology used: Sub-cellular organisms;15,8;8,6;55,9;74,6;33,3;
%Companies according to biotechnology used: Bio-computing;29,2;22,3;71,2;85,1;16,7;
%Companies according to biotechnology used: Nanobiotechnology;16,6;10,6;50;68,7;8,3;
%Companies according to biotechnology used: Other;12,7;14,2;1,7;7,5;0;
Companies in which biotechnology activities are:  Main and/or exclusive;653;615;29;2;7;
Companies in which biotechnology activities are: A secondary line of business;262;178;35;48;1;
Companies in which biotechnology activities are: A tool necessary for production;515;440;54;17;4;
%Companies by field(s) of ultimate application of biotechnology use: Human health;51;46;77;91;67;
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;19;16;19;70;25;
%Companies by field(s) of ultimate application of biotechnology use: Food products;33;32;23;79;0;
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;27;25;23;73;33;
%Companies by field(s) of ultimate application of biotechnology use: Environment;19;16;23;76;8;
%Companies by field(s) of ultimate application of biotechnology use: Industry;16;13;14;70;8;
Personnel in R&D in biotechnology (no. of persons);43.568;13.444;14.558;15.422;144;
Personnel in R&D in biotechnology (no. of persons): Researchers;28.824;7.378;8.979;12.379;88;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;14.744;6.066;5.579;3.043;56;
Personnel in R&D in biotechnology (no. of persons): women;24.402;7.501;9.115;7.689;97;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;15.288;4.052;5.262;5.916;58;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;9.115;3.450;3.853;1.773;39;
Personnel in R&D in biotechnology (FTE);30.003,8;9.401,9;10.846,1;9.663,9;91,9;
Personnel in R&D in biotechnology (FTE): Researchers;19.421,7;5.398,3;6.270,9;7.692,1;60,4;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;10.582,1;4.003,6;4.575,2;1.971,8;31,5;
Personnel in R&D in biotechnology (FTE): women;17.268,4;5.426,2;6.853,1;4.923,3;65,8;
Personnel in R&D in biotechnology (FTE): (women) Researchers;10.512,7;3.016,4;3.680,8;3.774,1;41,4;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;6.755,7;2.409,8;3.172,3;1.149,2;24,4;
Internal expenditure on R&D (thousands of euros);2.059.394;897.333;678.685;477.628;5.748;
1) By nature of the expense: Current expenses;1.896.836;817.409;632.188;441.712;5.526;
1.1) Remuneration to researchers;815.653;295.705;238.938;279.152;1.859;
1.2) Remuneration to technicians and assistants;346.532;156.853;127.778;61.050;851;
1.3) Other current expenses;734.651;364.852;265.472;101.510;2.817;
2) By nature of the expense: Capital expenses;162.558;79.924;46.497;35.916;221;
2.1) Land and buildings;21.618;10.272;4.863;6.483;0;
2.2) Equipment and instruments;125.071;56.609;40.467;27.780;216;
2.3) Acquisition of specific R+D software;7.349;4.839;969;1.541;1;
2.4) Otros productos de propiedad intelectual específicos para I+D;8.519;8.203;199;112;5;
1.1) By origin of the funds: Own funds;772.786;613.097;68.653;88.724;2.311;
1.2) By origin of the funds: From companies;222.014;86.085;110.014;25.119;796;
1.3) By origin of the funds: Public Administration funds;824.067;92.140;416.365;314.573;989;
1.4) By origin of the funds: From Universities;6.337;853;1.238;4.246;0;
1.5) By origin of the funds: From non profit private institutions;29.754;4.682;15.618;8.422;1.032;
1.6) By origin of the funds: Foreign funds;204.436;100.476;66.798;36.544;619;
Purchase of services R & D in Biotechnology to (thousands of euros);114.577;85.011;21.442;7.429;695;
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;81.403;54.243;19.374;7.134;652;
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;33.174;30.768;2.068;294;43;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;42,2;39,2;61;58,2;75;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;10,9;11,7;3,4;10,4;8,3;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;16,2;12,5;41,5;38,8;25;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;13,6;10,9;29,7;34,3;16,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;17,1;14,3;31,4;41,8;25;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;19;17;29;40;25;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;14,5;15;9,3;10,4;33,3;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;36;36;37;34;58;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;48,6;46,7;60,2;59,7;66,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;19;19;21,2;13,4;25;
%Companies that have requested biotechnology patents in Biotechnology;22,9;17,3;53,4;73,1;8,3;
Number of patents requested;1.991;681;698;611;1;
Notas:
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total Companies from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute